POCKETALK Corporation (Headquarters: 7-1 Nihonbashi-Kabutocho, Chuo-ku, Tokyo; Representative Executive Officer and President: Noriyuki Matsuda) is pleased to announce that its European subsidiary (hereinafter referred to as "POCKETALK B.V.") achieved its first half-year profitability in the period from January to June 2026. This achievement follows previous single-month profitability and operating profitability in the first quarter of 2026 (January-March), demonstrating the continuation of a system capable of stably generating profits over a sustained period.
Under its mission to "eliminate the language barrier," POCKETALK has provided its AI interpreter "POCKETALK" series globally, promoting its adoption in overseas markets, including Europe and the United States, primarily in the medical, public, and corporate sectors.
In conducting global business, it is crucial to dynamically transition to business operations suitable for each country and region in response to changes in market environments, customer needs, and sales channels. With this philosophy in mind, POCKETALK is shifting its overseas business operations towards a more profitability-focused model while pursuing growth opportunities.
As a pioneering example, POCKETALK has been building its business foundation in the European market and optimizing its sales structure. By improving sales efficiency through the development of a distributor network, and by reviewing personnel structures and promotional expenses, POCKETALK has achieved highly profitable business operations, resulting in an annual improvement of approximately 300 million yen in operating profit. The achievement of half-year operating profit this time demonstrates the continued positive results of these initiatives.
In Europe, adoption has been particularly strong in the medical field, with the device currently in use at over 300 medical and welfare-related facilities.
Furthermore, a third-party demonstration evaluation at Salisbury NHS Foundation Trust, a public general hospital belonging to the UK's National Health Service (NHS) (*), confirmed the immediacy and on-site convenience compared to traditional telephone interpretation, as well as an improvement in the quality of care through direct communication with patients compared to human interpreters. Additionally, in this evaluation, 100% of users responded that they "would like to use POCKETALK again." These results, conducted by a public healthcare institution, demonstrate the effectiveness of POCKETALK's services in the European healthcare market.
POCKETALK views the achievement of half-year operating profit as a significant step indicating the steady progress of the shift to a profitability-focused business operation model and the expanding adoption, particularly in the medical field. Moving forward, POCKETALK aims for further stable growth with an efficient structure, focusing on high-demand areas such as the medical field.
POCKETALK Corporation, with its mission to "eliminate the language barrier," has expanded the provision of its "POCKETALK" series worldwide, aiming to realize a world where people can communicate in their native languages and understand each other deeply. While responding to the growing multilingual needs around the world, POCKETALK will promote business development tailored to the characteristics of each region.
(*) NHS: Abbreviation for the UK's public healthcare system, the National Health Service.
[About the AI Interpreter "POCKETALK S2"]
"POCKETALK S2" is the latest model launched in October 2024. It can translate 91 languages into voice and text, and one language into text only. Compared to previous models, the number of countries and regions where communication is possible without Wi-Fi has expanded, and it has built-in mobile communication capabilities that allow it to be used as is in over 170 countries and regions worldwide, even without Wi-Fi. Furthermore, the battery life has been significantly improved, making it updated for use in all situations.
Security is further enhanced through integration with "POCKETALK Analytics," and by complying with global security standards, it can be used with peace of mind not only for personal use but also for adoption by companies, organizations, and local governments.
Details URL: https://pocketalk.jp/device
[About AI Simultaneous Interpreter "POCKETALK - Sentio"]
AI Simultaneous Interpreter "Sentio" allows you to understand conversations in 42 languages in real-time with voice and text in 77 languages, making it feel as if you have a dedicated simultaneous interpreter. It can be used via a web browser on smartphones, PCs, and tablet devices with internet connectivity. A key feature is its usability not only for online meetings but also for face-to-face interactions.
Details URL: https://pocketalk.jp/forbusiness/livetranslation
[About the AI Simultaneous Interpreter "POCKETALK X"]
"POCKETALK X" is a stationary AI simultaneous interpreter developed to enable natural conversations in multiple languages face-to-face.
Equipped with a dual-sided display, it instantly translates and displays each other's words, enabling a natural conversational experience. Furthermore, it is designed for intuitive and secure use in public spaces, featuring precise voice recognition with high-sensitivity microphones, a smart sensor that automatically activates the screen upon detecting a person's presence, and privacy features such as one-touch deletion of conversation history.
<Sales Start Period>
Scheduled for 2026
<Sales Prices and Plans>
Rental Plan
Monthly fee: 20,000 yen + tax
Annual fee: 200,000 yen + tax
Purchase Plan
Initial cost: 400,000 yen + tax (includes device cost and 2 years of software usage fees)
Software usage fee from the 3rd year onwards: 120,000 yen + tax per year
Free trial application: https://pocketalk.jp/pt-x
FACT BOX
- Source: PR TIMES
- Category: 財務
- Organizations: POCKETALK B.V / Salisbury NHS Foundation Trust / NHS